A Ramdomized Study to Evaluate Safety and Efficacy of Transitioning Therapy from Alendronate to Denosumab (AMG 12) in postmenopausal women with low bone mineral density

  • Muse, Kenneth (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date12/1/0611/30/08